Track topics on Twitter Track topics that are important to you
CHICAGO, IL -- (Marketwired) -- 06/01/15 -- Twenty Japanese companies will exhibit in the Japan Pavilion (Booth 3649) at the 2015 BIO International Convention (BIO 2015), to be held at the Pennsylvania Convention Center in Philadelphia. The event is scheduled to run from June 15-18. The Japan Pavilion is organized by the Japan External Trade Organization (JETRO), the Japanese government's economic development and trade promotion organization.
The annual BIO Convention, organized by the Biotechnology Industry Organization, is the largest event for the biotechnology sector. More than 16,000 people from all over the world are expected to attend BIO 2015.
The companies in the Japan Pavilion represent some of Japan's most innovative biotechnology and life science companies. Key technologies to be exhibited at BIO 2015 include new treatments for oncology, pain management, cognitive and neurological disorders; advancements in regenerative medicine; drug discovery tools; and contract manufacturing and R&D. Five companies will be exhibiting in the Japan Pavilion for the first time:
The Japan delegates will also participate in BIO's One-on-One Partnering meetings. The exhibitors are eager to meet new strategic development and distribution partners. The full list of the Japan Pavilion exhibitors is available online at http://www.jetro.go.jp/usa/topics/bio2015.html
During the convention, Hidetaka Nishimura, Director of the Bio-Industry Division at Japan's Ministry of Trade, Economy & Industry (METI) will participate in the Global Innovation Hub Spotlight program. Mr. Nishimura will make a presentation on Japan's efforts to accelerate regenerative medicine. As a part of Prime Minister Shinzo Abe's economic revitalization plan, new laws have been enacted to speed the process of development and commercialization for innovative regenerative therapies. The Japanese government is also aggressively increasing funding for stem cell research. Japan's Global Innovation Hub presentation is scheduled for 10:45 AM on Wednesday, June 17 in Room 110AB.
As the world's second-largest life science market, Japan accounts for approximately 10% of global drug and medical device sales. The international accounting firm of Deloitte Touche Tohmatsu valued Japan's pharmaceutical market at approximately $115 billion in 2013; by 2018, it is expected to increase to more than $128 billion.
JETRO promotes trade and investment between Japan and the rest of the world. With more than 70 overseas offices and 40 in Japan, JETRO carries out a range of activities, including: facilitating foreign direct investment into Japan; helping Japanese firms maximize their export potential; and promoting Japanese products abroad. In the life science sector, JETRO provides market information and consulting to Japanese companies interested in entering foreign markets and to foreign companies interested in expanding into Japan. JETRO has organized the Japan Pavilion at the BIO Convention since 2003.Robert Corder Project Coordinator JETRO Chicago TEL 312-833-6000 EMAIL NEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...